This article is more than 5 years old. Information may no longer be current.
Medtronic introduces new inflatable bone tamp for treatment of vertebral compression fractures
Click Here to Manage Email Alerts
Medtronic Inc. announced in a press release that the U. S. Food and Drug Administration (FDA) has cleared the Kyphon Xpander II Inflatable Bone Tamp (IBT) for the treatment of vertebral compression fractures with minimally invasive Kyphon Balloon Kyphoplasty.
The new IBT is designed to have an improved, predetermined inflation pattern and exert greater lifting force than that of the Kyphon Xpander IBT, Medtronic noted in the press release. It also gives physicians the ability to maintain inflation of one IBT while delivering polymethylmethacrylate (PMMA) bone cement on the contralateral side of the vertebrae. Kyphon Xpander II will enter into limited market release in November in the United States. The product is expected to be available internationally in 2011.
“Xpander II joins a host of innovative new products in what is the largest launch in our division’s history,” Alex DiNello, vice president and general manager of the Kyphon Products Division, stated in the press release. “Xpander II is the flagship product in our division’s revitalized product platform, which also includes the Kyphon Express Curette, Kyphon ActivOs 10 Bone Cement with Hydroxyapatite, and the Kyphon Cement Delivery System. These new products join the rest of our product family in providing our customers with performance they can count on in treating vertebral compression fractures.”